Rewalk Robotics Ltd. received U.S. FDA clearance for its second robotic medical device for people with lower limb disability. Known as the Restore soft exosuit system, it is cleared for use as part of physical therapy to aid stroke survivors with mobility problems. The Israeli company, which has additional headquarters in Marlborough, Mass., and Berlin, anticipates that the Restore soft exosuit may outstrip its existing Rewalk Personal 6.0 robotic exoskeleton for home use by patients with paralysis from spinal cord injury – and substantially contribute to a path to breakeven and profitability in the next couple of years.